Furthermore, ATAD2 knockdown in GC cells led to reduced levels of cyclin D1, cyclin E, E2F1 and RB phosphorylation, thus inhibiting proliferation and cell cycle progression (129). The gene discussed is E2F1; the disease is gastric cancer.